菜单
Telephone sharing button Contact Us linkedin sharing button LinkedIn wechat sharing button YouTube wechat sharing button Twitter mailbox sharing button info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

Webinar

20/05/2024

An Advanced and Highly Flexible Single B Cell Technology Platform for Antibody Discovery
Jieying Liu
Executive Director (Head of Hybridoma and Assay Center), WuXi Biologics

Single B cell screening is an emerging technology for antibody discovery. The platform is ideal because it allows researchers to discover physiologically relevant therapeutic mAbs from any species without significant investment. In this presentation, Dr. Liu introduces a fast, ultra-high throughput and highly versatile, single B cell platform developed by WuXi Biologics that overcomes many of the limitations of traditional antibody discovery platforms. We share several case studies on the discovery of antibodies to various targets using the single B cell screening technology.

Discuss This Webinar

To discuss this webinar, please complete the form on the following page to connect with our experts.

Connect with our Experts